These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

180 related items for PubMed ID: 8820460

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Piperacillin/tazobactam: a critical review of the evolving clinical literature.
    Sanders WE, Sanders CC.
    Clin Infect Dis; 1996 Jan; 22(1):107-23. PubMed ID: 8824974
    [Abstract] [Full Text] [Related]

  • 5. Piperacillin/tazobactam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic potential.
    Bryson HM, Brogden RN.
    Drugs; 1994 Mar; 47(3):506-35. PubMed ID: 7514977
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Efficacy and safety of piperacillin/tazobactam in intra-abdominal infections.
    Vestweber KH, Grundel E.
    Eur J Surg Suppl; 1994 Mar; (573):57-60. PubMed ID: 7524797
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. In vitro antimicrobial activity of piperacillin/tazobactam in comparison with other broad-spectrum beta-lactams.
    Roland RK, Mendes RE, Silbert S, Bolsoni AP, Sader HS.
    Braz J Infect Dis; 2000 Oct; 4(5):226-35. PubMed ID: 11063554
    [Abstract] [Full Text] [Related]

  • 11. [A combined dosage form of piperacillin and tazobactam--tazocin].
    Iakovlev SV.
    Antibiot Khimioter; 1997 Oct; 42(2):5-16. PubMed ID: 9124994
    [No Abstract] [Full Text] [Related]

  • 12. Beta-lactamase inhibitor combinations with extended-spectrum penicillins: factors influencing antibacterial activity against enterobacteriaceae and Pseudomonas aeruginosa.
    Lister PD.
    Pharmacotherapy; 2000 Sep; 20(9 Pt 2):213S-218S; discussion 224S-228S. PubMed ID: 11001328
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Efficacy, safety and tolerance of parenteral piperacillin/tazobactam in the treatment of patients with lower respiratory tract infections.
    Mouton Y, Leroy O, Beuscart C, Chidiac C, Senneville E, Ajana F, Lecocq P.
    J Antimicrob Chemother; 1993 Jan; 31 Suppl A():87-95. PubMed ID: 8383658
    [Abstract] [Full Text] [Related]

  • 15. Comparative in vitro activity of beta-lactam/beta-lactamase inhibitor combinations against gram negative bacteria.
    Mohanty S, Singhal R, Sood S, Dhawan B, Das BK, Kapil A.
    Indian J Med Res; 2005 Nov; 122(5):425-8. PubMed ID: 16456257
    [Abstract] [Full Text] [Related]

  • 16. [Fundamental and clinical studies on tazobactam/piperacillin in the pediatric field].
    Kitamura K, Nishimori H, Ihara T, Kamiya H.
    Jpn J Antibiot; 1998 Jun; 51(6):407-12. PubMed ID: 9755830
    [Abstract] [Full Text] [Related]

  • 17. Clinical use of beta-lactamase inhibitors in combination with extended-spectrum penicillins.
    Jones RN.
    Am J Health Syst Pharm; 1995 Mar 15; 52(6 Suppl 2):S29-33. PubMed ID: 7606587
    [Abstract] [Full Text] [Related]

  • 18. [Bacteriological and clinical evaluation tazobactam/piperacillin in infectious diseases in surgical field].
    Shinagawa N, Yura J, Mashita K, Matsuno S, Rikiyama T, Hirayama T, Tanaka T, Otsuka K, Iwai S, Nakagawa Y.
    Jpn J Antibiot; 1995 Mar 15; 48(3):346-67. PubMed ID: 7752449
    [Abstract] [Full Text] [Related]

  • 19. Ceftolozane/Tazobactam: A Novel Cephalosporin/β-Lactamase Inhibitor Combination.
    Cho JC, Fiorenza MA, Estrada SJ.
    Pharmacotherapy; 2015 Jul 15; 35(7):701-15. PubMed ID: 26133315
    [Abstract] [Full Text] [Related]

  • 20. Different ratios of the piperacillin-tazobactam combination for treatment of experimental meningitis due to Klebsiella pneumoniae producing the TEM-3 extended-spectrum beta-lactamase.
    Leleu G, Kitzis MD, Vallois JM, Gutmann L, Decazes JM.
    Antimicrob Agents Chemother; 1994 Feb 15; 38(2):195-9. PubMed ID: 8192442
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.